Prescribing and Advocating for Immunomodulators in Dermatology Practice

The integration of biologicBiologic and small molecule therapies has revolutionized dermatological care, offering efficacy with a reduced side effect profile. However, accessibility remains a challenge due to a myriad of barriers, including financial constraints, geographic disparities, and insurance barriers. This chapter reviews the multifaceted approach needed to bridge the gap between theory and practice in implementing key therapies. Key strategies include physician education, coordination of care through biologicBiologic coordinatorsCoordinator and specialty pharmacies, advocacyAdvocacy efforts to challenge restrictive insurance practices, and ongoing research to optimize treatmentTreatment outcomes. By addressing these challenges collectively, stakeholders can ensure equitable accessAccess to life-changing treatments and advance the field of dermatological medicine towards personalized and effective care.